South Africa - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Human and Animal Blood in South Africa - 2023
Contents:
- Price for Human and Animal Blood in South Africa (CIF) - 2023
- Price for Human and Animal Blood in South Africa (FOB) - 2022
- Imports of Human and Animal Blood in South Africa
- Exports of Human and Animal Blood in South Africa
Price for Human and Animal Blood in South Africa (CIF) - 2023
In July 2023, the average human and animal blood import price amounted to $28,299 per ton, dropping by -41.5% against the previous month. In general, the import price, however, showed mild growth. The pace of growth appeared the most rapid in September 2022 when the average import price increased by 391% against the previous month. As a result, import price reached the peak level of $121K per ton. From October 2022 to July 2023, the average import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In July 2023, the country with the highest price was Denmark ($112K per ton), while the price for Argentina ($20,666 per ton) was amongst the lowest.
From July 2022 to July 2023, the most notable rate of growth in terms of prices was attained by Denmark (+13.4%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Human and Animal Blood in South Africa (FOB) - 2022
In 2022, the average human and animal blood export price amounted to $45,621 per ton, dropping by -19.3% against the previous year. Overall, the export price, however, continues to indicate a moderate increase. The pace of growth appeared the most rapid in 2015 an increase of 138% against the previous year. The export price peaked at $70,506 per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Zimbabwe ($231,995 per ton), while the average price for exports to China ($5,214 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Sudan (+16.4%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Human and Animal Blood in South Africa
In 2022, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported into South Africa reduced to 619 tons, with a decrease of -11.7% compared with 2021. Over the period under review, imports continue to indicate a abrupt downturn. The pace of growth appeared the most rapid in 2021 with an increase of 4.6%.
In value terms, human and animal blood imports plummeted to $27M in 2022. In general, imports saw a deep slump. The most prominent rate of growth was recorded in 2021 with an increase of 61% against the previous year. As a result, imports reached the peak of $52M, and then reduced notably in the following year.
| Import of Human and Animal Blood in South Africa (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| United States | 8.4 | 6.2 | 10.1 | 6.9 | -6.3% |
| Argentina | 1.6 | 2.9 | 0.9 | 4.9 | 45.2% |
| United Kingdom | 2.1 | 1.1 | 3.2 | 3.9 | 22.9% |
| Ireland | 6.5 | 7.7 | 9.6 | 2.4 | -28.3% |
| Germany | 3.7 | 2.7 | 2.7 | 2.2 | -15.9% |
| Netherlands | 0.4 | 0.4 | 11.3 | 1.9 | 68.1% |
| Denmark | 5.4 | 4.9 | 5.6 | 1.3 | -37.8% |
| Switzerland | 1.7 | 1.6 | 1.7 | 0.8 | -22.2% |
| Spain | 0.1 | 0.4 | 0.1 | N/A | 0.0% |
| Canada | 0.8 | 0.5 | 0.4 | N/A | -29.3% |
| Others | 3.7 | 3.9 | 6.7 | 3.1 | -5.7% |
| Total | 34.6 | 32.4 | 52.3 | 27.4 | -7.5% |
Top Suppliers of Human and Animal Blood to South Africa in 2022:
- Argentina (340.6 tons)
- Ireland (61.7 tons)
- United States (48.6 tons)
- Denmark (35.3 tons)
- Germany (25.4 tons)
- Switzerland (18.4 tons)
- Spain (16.3 tons)
- Netherlands (14.0 tons)
- United Kingdom (10.1 tons)
- Canada (0.2 tons)
Exports of Human and Animal Blood in South Africa
In 2022, approx. 72 tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported from South Africa; which is down by -17.4% compared with the previous year's figure. Over the period under review, exports saw a significant contraction.
In value terms, human and animal blood exports contracted sharply to $3.3M in 2022. In general, exports recorded a deep setback. The growth pace was the most rapid in 2021 when exports increased by 1.4% against the previous year.
| Export of Human and Animal Blood in South Africa (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Namibia | 1,039 | 918 | 844 | 587 | -17.3% |
| Botswana | 977 | 1,051 | 652 | 481 | -21.0% |
| Mauritius | 262 | 219 | 216 | 429 | 17.9% |
| Zambia | 337 | 215 | 591 | 370 | 3.2% |
| Sudan | 1.0 | N/A | N/A | 305 | 573.1% |
| Zimbabwe | 513 | 703 | 1,806 | 305 | -15.9% |
| Mozambique | 59.8 | 57.5 | 13.8 | 121 | 26.5% |
| Belgium | 1.0 | 0.4 | 0.1 | 94.2 | 355.0% |
| Swaziland | 30.3 | 63.3 | 57.1 | 79.8 | 38.1% |
| Malawi | 111 | 130 | 106 | 56.8 | -20.0% |
| Bolivia | N/A | N/A | N/A | 55.6 | 0% |
| Nigeria | 40.5 | 11.3 | 4.1 | 21.5 | -19.0% |
| China | N/A | N/A | N/A | 11.0 | 0% |
| Others | 2,256 | 1,508 | 653 | 380 | -44.8% |
| Total | 5,627 | 4,876 | 4,944 | 3,296 | -16.3% |
Top Export Markets for Human and Animal Blood from South Africa in 2022:
- Namibia (13.9 tons)
- Belgium (12.9 tons)
- Botswana (6.6 tons)
- Mozambique (6.3 tons)
- Swaziland (5.8 tons)
- Zambia (5.1 tons)
- Sudan (3.1 tons)
- Mauritius (3.0 tons)
- Bolivia (2.4 tons)
- Nigeria (2.3 tons)
- China (2.1 tons)
- Malawi (1.7 tons)
- Zimbabwe (1.3 tons)
This report provides an in-depth analysis of the market for human and animal blood in South Africa. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
- South Africa
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in South Africa
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
357
This report provides an in-depth analysis of the market for human and animal blood in South Africa.
449
This report provides an in-depth analysis of the antisera market in South Africa.
468
This report provides an in-depth analysis of the vaccine market in South Africa.
473
This report provides an in-depth analysis of the biological product market in South Africa.
602
This report provides an in-depth analysis of the veterinary medicine vaccines market in South Africa.
646
This report provides an in-depth analysis of the global market for human and animal blood.
2284
This report provides an in-depth analysis of the global antisera market.
2846
This report provides an in-depth analysis of the global vaccine market.
559
This report provides an in-depth analysis of the global biological product market.
753
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
245
Overall, there is a robust growth in imports, with the import value of Human And Animal Blood reaching $4M in July 2023.
272
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1149
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1074
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1256
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1261
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3232
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
499
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
592
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1231
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
